Back to Search
Start Over
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome
- Source :
- Cancer. 129:1704-1713
- Publication Year :
- 2023
- Publisher :
- Wiley, 2023.
Details
- ISSN :
- 10970142 and 0008543X
- Volume :
- 129
- Database :
- OpenAIRE
- Journal :
- Cancer
- Accession number :
- edsair.doi.dedup.....75234af541a1ffd87d4f63defcaf092a